Búsqueda | Portal de Búsqueda de la BVS España

1.

Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.

Reeve, Bryce B; Chen, Ronald C; Moore, Dominic T; Deal, Allison M; Usinger, Deborah S; Lyons, Jessica C; Talcott, James A.

BJU Int; 114(6b): E74-E81, 2014 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-24588845

2.

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.

Talcott, James A; Manola, Judith; Chen, Ronald C; Clark, Jack A; Kaplan, Irving; D'Amico, Anthony V; Zietman, Anthony L.

BJU Int; 114(4): 511-6, 2014 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-24112602

3.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Gray, Phillip J; Paly, Jonathan J; Yeap, Beow Y; Sanda, Martin G; Sandler, Howard M; Michalski, Jeff M; Talcott, James A; Coen, John J; Hamstra, Daniel A; Shipley, William U; Hahn, Stephen M; Zietman, Anthony L; Bekelman, Justin E; Efstathiou, Jason A.

Cancer; 119(9): 1729-35, 2013 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-23436283

4.

In the Clinic. Prostate Cancer.

Talcott, James A.

Ann Intern Med; 163(11): ITC1-12, 2015 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-26618297

5.

Race, healthcare access and physician trust among prostate cancer patients.

Do, Young Kyung; Carpenter, William R; Spain, Pamela; Clark, Jack A; Hamilton, Robert J; Galanko, Joseph A; Jackman, Anne; Talcott, James A; Godley, Paul A.

Cancer Causes Control; 21(1): 31-40, 2010 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19777359

6.

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

Talcott, James A; Rossi, Carl; Shipley, William U; Clark, Jack A; Slater, Jerry D; Niemierko, Andrzej; Zietman, Anthony L.

JAMA; 303(11): 1046-53, 2010 Mar 17.

Artículo en Inglés | MEDLINE | ID: mdl-20233822

7.

Primary care physician-led health reform.

Talcott, James A.

JAMA; 312(14): 1471-2, 2014 Oct 08.

Artículo en Inglés | MEDLINE | ID: mdl-25291590

8.

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update: ASCO Guideline Q and A.

Virgo, Katherine S; Rumble, R Bryan; Talcott, James A.

JCO Oncol Pract; 19(10): 843-846, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37463395

9.

Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume.

Petit, Joshua H; Gluck, Clifford; Kiger, W S; Laury Henry, D; Karasiewicz, Carol; Talcott, James A; Berg, Solomon; Holupka, Edward J; Kaplan, Irving D.

Brachytherapy; 6(4): 267-71, 2007.

Artículo en Inglés | MEDLINE | ID: mdl-17959423

10.

Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer.

Talcott, James A; Clark, Jack A; Lee, Insu P.

BMC Complement Altern Med; 7: 32, 2007 Oct 29.

Artículo en Inglés | MEDLINE | ID: mdl-17967191

11.

Risk Assessment Models for Febrile Neutropenia: The Reification of Clinical Decision Making.

Talcott, James A.

JCO Oncol Pract; 18(12): 823-825, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36067455

12.

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

Jang, Joanne W; Drumm, Michael R; Efstathiou, Jason A; Paly, Jonathan J; Niemierko, Andrzej; Ancukiewicz, Marek; Talcott, James A; Clark, Jack A; Zietman, Anthony L.

Cancer Med; 6(7): 1827-1836, 2017 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-28560840

13.

Reply to A. K. Tewari et al.

Talcott, James A; Virgo, Katherine S.

J Clin Oncol; 39(26): 2969-2970, 2021 09 10.

Artículo en Inglés | MEDLINE | ID: mdl-33989012

14.

The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men.

Allensworth-Davies, Donald; Talcott, James A; Heeren, Timothy; de Vries, Brian; Blank, Thomas O; Clark, Jack A.

LGBT Health; 3(1): 49-56, 2016 02.

Artículo en Inglés | MEDLINE | ID: mdl-26698658

15.

Patients' perceptions of quality of life after treatment for early prostate cancer.

Clark, Jack A; Inui, Thomas S; Silliman, Rebecca A; Bokhour, Barbara G; Krasnow, Steven H; Robinson, Richard A; Spaulding, Monica; Talcott, James A.

J Clin Oncol; 21(20): 3777-84, 2003 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-14551296

16.

Time course and predictors of symptoms after primary prostate cancer therapy.

Talcott, James A; Manola, Judithy; Clark, Jack A; Kaplan, Irving; Beard, Clair J; Mitchell, Sonya P; Chen, Ronald C; O'Leary, Michael P; Kantoff, Philip W; D'Amico, Anthony V.

J Clin Oncol; 21(21): 3979-86, 2003 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-14581420

17.

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

Loblaw, D Andrew; Mendelson, David S; Talcott, James A; Virgo, Katherine S; Somerfield, Mark R; Ben-Josef, Edgar; Middleton, Richard; Porterfield, Henry; Sharp, Stewart A; Smith, Thomas J; Taplin, Mary Ellen; Vogelzang, Nicholas J; Wade, James L; Bennett, Charles L; Scher, Howard I.

J Clin Oncol; 22(14): 2927-41, 2004 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-15184404

18.

Quality of life in prostate cancer.

Talcott, James A; Clark, Jack A.

Eur J Cancer; 41(6): 922-31, 2005 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-15808958

19.

Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.

Tsai, Henry K; Manola, Judith; Abner, Anthony; Talcott, James A; D'Amico, Anthony V; Beard, Clair.

Urol Oncol; 23(4): 230-7, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-16018937

20.

Suspected spinal cord compression in cancer patients: a multidisciplinary risk assessment.

Lu, Charles; Gonzalez, Ramon G; Jolesz, Ferenc A; Wen, Patrick Y; Talcott, James A.

J Support Oncol; 3(4): 305-12, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-16092602

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

In the Clinic. Prostate Cancer.

Race, healthcare access and physician trust among prostate cancer patients.

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

Primary care physician-led health reform.

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update: ASCO Guideline Q and A.

Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume.

Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer.

Risk Assessment Models for Febrile Neutropenia: The Reification of Clinical Decision Making.

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

Reply to A. K. Tewari et al.

The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men.

Patients' perceptions of quality of life after treatment for early prostate cancer.

Time course and predictors of symptoms after primary prostate cancer therapy.

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

Quality of life in prostate cancer.

Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.

Suspected spinal cord compression in cancer patients: a multidisciplinary risk assessment.